Case Study

Reduce Product Loss In Biopharma To Save Costs

SUS

The customer, a global biotechnology company with a total turnover of > 5 billion USD, produces different drug substances (BDS) of highly valuables mABs in batch sizes from 10l to 700l for clinical phases up to commercialized products. The BDS is frozen < -85°C (-121°F) and shipped within Europe or transatlantic for max. 200 hours with dry ice and stored. At the fill & finish site, the BDS is thawed for producing the drug product.

The biotech company planned to rely on single-use bioprocess containers as preferred primary packaging for BDS bulk filling, freezing, storing and shipping. This was due to various advantages of single-use bags like filling in a closed system, higher volumes, scalability and high storage density.

But the biggest challenge of single use bags was the high loss rate of 0,5% to 5% due to their sensitivity at sub-zero temperatures. The product loss rate depends on the bag used, the clam shell of the product, the process and the shipper/shipping route. Therefore, the goal was to reduce the current product loss below 0.5%.

Continue reading to learn how they set up a cold chain process and implemented robust technologies around the brittle single use bag and to consequentially reduce product loss.

VIEW THE CASE STUDY!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Cell & Gene